Please login to the form below

Not currently logged in
Email:
Password:

Arquer Diagnostics appoints CEO

Nadia Whittley takes up the lead role at the oncology diagnostics firm

Arquer Diagnostics Nadia WhittleySunderland, UK-based Arquer Diagnostics has appointed Nadia Whittley as its new chief executive officer with immediate effect.

Whittley joins the oncology diagnostic specialist from Tefen Management Consulting, where she was partner and managing director, Europe, responsible for the strategic direction of the company's life science business unit across EMEA.

Previously, she has served as chief executive of Alium Medical, a UK-based global supply service, managing director of medical devices, EMEA at Allergan, and marketing director for interventional cardiology, EMEA at Boston Scientific International.

Dr Sandy Primrose, chairman of Arquer Diagnostics, said: “I would like to welcome Nadia and am delighted that we have someone with her commercial background as our new chief executive officer.

“Her experience of successfully launching new technologies across multiple regions and her knowledge of the sector make her a real asset to the business, particularly as we move forward to commercialise our MCM5-ELISA diagnostic test.”

15th December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics